MX9601175A - Carotenoides, retinoides y polienos conjugados relacionados, en estado oxidado, y sus fracciones y compuestos derivados, utiles como inductores de la diferenciacion de celulas, agentes citostaticos y agentes anti-tumorales. - Google Patents
Carotenoides, retinoides y polienos conjugados relacionados, en estado oxidado, y sus fracciones y compuestos derivados, utiles como inductores de la diferenciacion de celulas, agentes citostaticos y agentes anti-tumorales.Info
- Publication number
- MX9601175A MX9601175A MX9601175A MX9601175A MX9601175A MX 9601175 A MX9601175 A MX 9601175A MX 9601175 A MX9601175 A MX 9601175A MX 9601175 A MX9601175 A MX 9601175A MX 9601175 A MX9601175 A MX 9601175A
- Authority
- MX
- Mexico
- Prior art keywords
- oxidized
- carotene
- vitamin
- beta
- fractions
- Prior art date
Links
- 235000021466 carotenoid Nutrition 0.000 title abstract 4
- 150000001747 carotenoids Chemical class 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000000824 cytostatic agent Substances 0.000 title abstract 2
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 230000004069 differentiation Effects 0.000 title 1
- 150000004291 polyenes Chemical class 0.000 title 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 abstract 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 abstract 5
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 abstract 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 abstract 5
- 235000013734 beta-carotene Nutrition 0.000 abstract 5
- 239000011648 beta-carotene Substances 0.000 abstract 5
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 abstract 5
- 229960002747 betacarotene Drugs 0.000 abstract 5
- 235000019155 vitamin A Nutrition 0.000 abstract 5
- 239000011719 vitamin A Substances 0.000 abstract 5
- 229940045997 vitamin a Drugs 0.000 abstract 5
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 abstract 5
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 abstract 4
- 230000000694 effects Effects 0.000 abstract 3
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 abstract 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 abstract 2
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 abstract 2
- 230000001093 anti-cancer Effects 0.000 abstract 2
- 235000012682 canthaxanthin Nutrition 0.000 abstract 2
- 239000001659 canthaxanthin Substances 0.000 abstract 2
- 229940008033 canthaxanthin Drugs 0.000 abstract 2
- 235000012661 lycopene Nutrition 0.000 abstract 2
- 239000001751 lycopene Substances 0.000 abstract 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 abstract 2
- 229960004999 lycopene Drugs 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 230000024245 cell differentiation Effects 0.000 abstract 1
- 230000001085 cytostatic effect Effects 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 231100000404 nontoxic agent Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 229930002330 retinoic acid Natural products 0.000 abstract 1
- 150000004492 retinoid derivatives Chemical class 0.000 abstract 1
- 229960001727 tretinoin Drugs 0.000 abstract 1
- 231100000588 tumorigenic Toxicity 0.000 abstract 1
- 230000000381 tumorigenic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/28—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of CHx-moieties
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
El beta-caroteno, licopeno y cantaxantina, como carotenoides representativos, y, en una extension menor, el ácido retinoico, un retinoide representativo, se someten a una oxidacion extensa para suministrar substancias, de las cuales el beta-caroteno oxidado es un modelo, las cuales tienen propiedades utiles como agentes no toxicos contra la proliferacion de células, tumores y virus tumorigénicos, y son utiles como promotores de la diferenciacion celular. Es evidente, del análisis químico de la mezcla altamente oxidada de productos de beta-caroteno, que ninguna de las varias formas de la vitamina A está presente o solo en cantidades menores. Asimismo, las actividades biologicas de la cantaxantina y licopeno oxidados, que forman la vitamina A, indican la presencia de substancias activas, diferentes de la vitamina A. Aunque las actividades citostáticas y de promocion de la diferienciacion del beta-caroteno oxidado se asemejan a las de la propia vitamina A, en general, sus efectos son más potentes, en una amplia variedad de circunstancias. Diferentemente de la vitamina A, el beta-caroteno oxidado, segun la invencion, no es toxico. El carotenoide oxidado es una mezcla de compuestos que se pueden dividir en un numero de fracciones, de acuerdo con el peso molecular y la polaridad. Las fracciones exhiben una actividad contra el cáncer comparable a, o mayor que, la actividad contra el cáncer comparable a, o mayor que, la actividad del carotenoide oxidado no fraccionado.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/288,315 US5475006A (en) | 1994-08-10 | 1994-08-10 | Extensively oxidized derivatives of carotenoids, retinoids and related conjugated polyenes useful as non-toxic cell-differentiation inducers, anti-proliferative agents, and anti-tumor agents |
| PCT/CA1995/000484 WO1996005160A1 (en) | 1994-08-10 | 1995-08-10 | Oxidized carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9601175A true MX9601175A (es) | 1997-06-28 |
Family
ID=23106590
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9601175A MX9601175A (es) | 1994-08-10 | 1995-08-10 | Carotenoides, retinoides y polienos conjugados relacionados, en estado oxidado, y sus fracciones y compuestos derivados, utiles como inductores de la diferenciacion de celulas, agentes citostaticos y agentes anti-tumorales. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5475006A (es) |
| EP (1) | EP0722431B1 (es) |
| JP (1) | JP3983800B2 (es) |
| KR (1) | KR100404724B1 (es) |
| CN (1) | CN1131939A (es) |
| AT (1) | ATE201394T1 (es) |
| AU (1) | AU704640B2 (es) |
| CA (1) | CA2171625C (es) |
| CZ (1) | CZ103896A3 (es) |
| DE (1) | DE69521020T2 (es) |
| ES (1) | ES2160172T3 (es) |
| FI (1) | FI961544A0 (es) |
| GB (1) | GB2297325B (es) |
| MX (1) | MX9601175A (es) |
| NZ (1) | NZ290769A (es) |
| PL (1) | PL184296B1 (es) |
| PT (1) | PT722431E (es) |
| WO (1) | WO1996005160A1 (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6432711B1 (en) * | 1993-11-03 | 2002-08-13 | Diacrin, Inc. | Embryonic stem cells capable of differentiating into desired cell lines |
| US7132458B2 (en) * | 1994-08-10 | 2006-11-07 | Chemaphor Inc. | Oxidized carotenoid fractions and ketoaldehyde useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents |
| US20040228871A1 (en) * | 1999-06-03 | 2004-11-18 | Tayyaba Hasan | Treatment and analysis of proliferative disorders |
| IL135335A (en) * | 2000-03-29 | 2013-12-31 | Lycored Natural Prod Ind Ltd | Use of Carotenoids in Preparing Pharmaceuticals to Prevent Adverse Effects from Hormones and Pharmaceuticals Containing Carotenoids |
| US20020031539A1 (en) * | 2000-08-30 | 2002-03-14 | The Brigham And Women's Hospital, Inc. | Oxidized forms of retinoic acid as ligands for peroxisome proliferator activated receptor gamma |
| US20050037048A1 (en) * | 2003-08-11 | 2005-02-17 | Young-Ho Song | Medical devices containing antioxidant and therapeutic agent |
| US20050064011A1 (en) * | 2003-08-11 | 2005-03-24 | Young-Ho Song | Implantable or insertable medical devices containing phenolic compound for inhibition of restenosis |
| WO2005079143A2 (en) * | 2004-02-19 | 2005-09-01 | Occell Inc. | Topical formulations for the treatment of skin conditions |
| MX2007003773A (es) * | 2004-09-28 | 2009-01-19 | Chemaphor Inc | Composiciones y metodos para promover ganancia de peso y conversion de alimentacion. |
| WO2007043046A2 (en) * | 2005-10-11 | 2007-04-19 | Lycored Ltd. | Carotenoid oxidation products as chemopreventive and chemotherapeutic agents |
| CA2648282A1 (en) * | 2006-04-05 | 2007-10-11 | Chemaphor Inc. | Carotenoid-containing dietary supplement |
| CN101970012A (zh) | 2007-09-14 | 2011-02-09 | 日东电工株式会社 | 药物载体 |
| NZ585620A (en) * | 2007-10-26 | 2013-03-28 | Ca Nat Research Council | Compositions and methods for enhancing immune response |
| EP2424512B1 (en) | 2009-04-30 | 2020-06-03 | Avivagen Inc. | Methods and compositions for improving the health of animals |
| PT3288546T (pt) | 2015-04-28 | 2022-01-11 | Avivagen Inc | Carotenoides oxidados e seus componentes para prevenção da enterite necrótica |
| JP2018528174A (ja) * | 2015-08-20 | 2018-09-27 | アイ.ビー.アール.イスラエリ バイオテクノロジー リサーチ リミテッド | 抗ウイルス活性を有するカロテノイド組成物およびその用途 |
| KR102454311B1 (ko) * | 2016-02-25 | 2022-10-14 | 아비바젠 인코포레이티드. | 식물 또는 미생물-유래된 카로티노이드-산소 공중합체 조성물, 이를 확인, 정량화 및 제조하는 방법, 및 그의 용도 |
| CN106614301A (zh) * | 2016-11-14 | 2017-05-10 | 鄂尔多斯市绿食保山羊食品有限公司 | 山羊的有机养殖方法 |
| KR102683182B1 (ko) * | 2021-11-12 | 2024-07-11 | 주식회사 에이펙셀 | 메타 아르세나이트 염을 포함하는 암 치료용 약학 조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2505869C3 (de) * | 1975-02-12 | 1978-05-18 | Basf Ag, 6700 Ludwigshafen | Verfahren zur Herstellung von symmetrischen Carotinoiden |
| DE2635802C2 (de) * | 1976-08-09 | 1984-03-01 | Basf Ag, 6700 Ludwigshafen | Verfahren zur Herstellung von symmetrischen Carotinoiden |
| US5225604A (en) * | 1989-11-27 | 1993-07-06 | Neurosearch A/S | Hydroxycarbonyl derivatives and process for making the same |
| DK595489D0 (da) * | 1989-11-27 | 1989-11-27 | Neurosearch As | Hydroxycarbonylderivater og fremgangsmaade til fremstilling af samme |
| US5310554A (en) * | 1992-10-27 | 1994-05-10 | Natural Carotene Corporation | High purity beta-carotene |
| US5358915A (en) * | 1993-02-12 | 1994-10-25 | American Colloid Company | Process for regenerating spent acid-activated bentonite clays and smectite catalysts |
-
1994
- 1994-08-10 US US08/288,315 patent/US5475006A/en not_active Expired - Lifetime
-
1995
- 1995-08-10 AU AU31600/95A patent/AU704640B2/en not_active Ceased
- 1995-08-10 AT AT95927612T patent/ATE201394T1/de active
- 1995-08-10 MX MX9601175A patent/MX9601175A/es unknown
- 1995-08-10 PL PL95313907A patent/PL184296B1/pl not_active IP Right Cessation
- 1995-08-10 WO PCT/CA1995/000484 patent/WO1996005160A1/en not_active Ceased
- 1995-08-10 CZ CZ961038A patent/CZ103896A3/cs unknown
- 1995-08-10 ES ES95927612T patent/ES2160172T3/es not_active Expired - Lifetime
- 1995-08-10 CN CN95190750A patent/CN1131939A/zh active Pending
- 1995-08-10 GB GB9604444A patent/GB2297325B/en not_active Expired - Fee Related
- 1995-08-10 DE DE69521020T patent/DE69521020T2/de not_active Expired - Lifetime
- 1995-08-10 FI FI961544A patent/FI961544A0/fi unknown
- 1995-08-10 CA CA002171625A patent/CA2171625C/en not_active Expired - Fee Related
- 1995-08-10 PT PT95927612T patent/PT722431E/pt unknown
- 1995-08-10 KR KR1019960701872A patent/KR100404724B1/ko not_active Expired - Fee Related
- 1995-08-10 EP EP95927612A patent/EP0722431B1/en not_active Expired - Lifetime
- 1995-08-10 JP JP50688496A patent/JP3983800B2/ja not_active Expired - Fee Related
- 1995-08-10 NZ NZ290769A patent/NZ290769A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GB2297325A (en) | 1996-07-31 |
| US5475006A (en) | 1995-12-12 |
| CZ103896A3 (en) | 1996-11-13 |
| CA2171625A1 (en) | 1996-02-22 |
| FI961544A7 (fi) | 1996-04-09 |
| NZ290769A (en) | 1998-08-26 |
| FI961544A0 (fi) | 1996-04-09 |
| DE69521020D1 (de) | 2001-06-28 |
| AU3160095A (en) | 1996-03-07 |
| AU704640B2 (en) | 1999-04-29 |
| JP3983800B2 (ja) | 2007-09-26 |
| JPH09504038A (ja) | 1997-04-22 |
| KR960704828A (ko) | 1996-10-09 |
| PT722431E (pt) | 2001-11-30 |
| GB2297325B (en) | 1999-01-13 |
| GB9604444D0 (en) | 1996-05-01 |
| ATE201394T1 (de) | 2001-06-15 |
| WO1996005160A1 (en) | 1996-02-22 |
| PL184296B1 (pl) | 2002-09-30 |
| DE69521020T2 (de) | 2001-11-15 |
| EP0722431A1 (en) | 1996-07-24 |
| CA2171625C (en) | 2008-10-14 |
| ES2160172T3 (es) | 2001-11-01 |
| HK1013814A1 (en) | 1999-09-10 |
| PL313907A1 (en) | 1996-08-05 |
| CN1131939A (zh) | 1996-09-25 |
| EP0722431B1 (en) | 2001-05-23 |
| KR100404724B1 (ko) | 2004-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9601175A (es) | Carotenoides, retinoides y polienos conjugados relacionados, en estado oxidado, y sus fracciones y compuestos derivados, utiles como inductores de la diferenciacion de celulas, agentes citostaticos y agentes anti-tumorales. | |
| Britton | Carotenoid research: History and new perspectives for chemistry in biological systems | |
| Stahl et al. | Antioxidant activity of carotenoids | |
| Stahl et al. | Biological activities of natural and synthetic carotenoids: induction of gap junctional communication and singlet oxygen quenching. | |
| Pryor et al. | Beta carotene: from biochemistry to clinical trials | |
| Begum et al. | Availability and utilization of pigments from microalgae | |
| Omaye et al. | β-Carotene: friend or foe? | |
| Goldstein et al. | Free radicals and carcinogenesis | |
| Guo et al. | Cis− trans isomerizations of β-carotene and lycopene: A theoretical study | |
| Bendich | Symposium conclusions: biological actions of carotenoids | |
| Rodriguez-Amaya | Carotenes and xanthophylls as antioxidants | |
| Blumberg | Considerations of the scientific substantiation for antioxidant vitamins and beta-carotene in disease prevention | |
| Heilbron | Some aspects of algal chemistry | |
| Boominathan et al. | Seaweed carotenoids for cancer therapeutics | |
| Deming et al. | Carotenoids: Linking chemistry, absorption, and metabolism to potential roles in human health and disease | |
| CN105792678A (zh) | 生物质配制物 | |
| Kadian et al. | Pharmacological effects of carotenoids: a review | |
| Zahra et al. | Comparative study of beta carotene determination by various methods: a review | |
| Kispert et al. | Chemistry of carotenoid radicals and complexes | |
| CN106232578B (zh) | 从生产类胡萝卜素的生物有机体分离类胡萝卜素的方法 | |
| Pintea et al. | Impact of Esterification on the Antioxidant Capacity of β-Cryptoxanthin. | |
| Palmer | The chemistry of vitamin A and substances having a vitamin A effect | |
| Stahl | Systemic photoprotection by carotenoids | |
| Amengual | Carotenoids and Human Health | |
| Deepa et al. | A Proficient singlet oxygen quenching carotenoid and Periodontal Disease. |